MAISON SOLUTIONS INC-A
MSSNASDAQTrading Snapshot
- Day Range
- $1.76 – $1.82
- 52-Week Range
- $1.24 – $74.50
- Volume
- $1.90B
- Avg Volume
- $2.39B
- Shares Outstanding
- 418,734
- Next Earnings
- Oct 21, 2026
Fundamentals Snapshot
- Annual Revenue
- $124M
- Last Q Revenue
- $30M
- P/E Ratio
- -0.1
- P/S Ratio
- 0.0x
- EPS (TTM)
- $-23.73
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +46.3%
Why Investors Own MSS
- ✓High-growth profile — revenue up +57.0% YoY with expanding US Equity exposure.
- ✓Healthy economics — 38% gross margin and 13% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
MAISON SOLUTIONS INC-A
MSS
StockOtter · stockotter.spaceAbout MAISON SOLUTIONS INC-A
Maison Solutions Inc., along with its affiliated entities, functions as a niche grocery retailer across California. The company offers a wide array of products, including fresh perishables like meats, seafood, fruits, and vegetables. Its inventory also features non-perishable goods such as kitchenware, canned foods, specialized Chinese and Asian spices and seasonings, and snack items. Additionally, its establishments provide alcoholic beverages, tobacco, lottery services, newspapers, reusable shopping bags, various household essentials, health and beauty products, general merchandise, pharmaceutical items, and fuel. Customers can acquire these items both in its physical stores and through its digital platform. Established in 2019, the firm was formerly known as Maison International, Inc. until it rebranded to Maison Solutions Inc. in September 2021, and its primary operations are based in Monterey Park, California.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Ratings
ⓘLatest News & Updates
Maison Solutions Inc. Receives Additional Nasdaq Notification Regarding Delayed Filing of Quarterly Report on Form 10-Q
MONTEREY PARK, CA / ACCESS Newswire / September 29, 2026 / Maison Solutions Inc. (Nasdaq:MSS) (the "Company") today announced that, on September 23, 2026, it received a notification letter from the Listing Qualifications
Oncolytics Biotech® Reports Accelerating Enrollment in Randomized REO 033 RAS-Mutant, MSS Colorectal Cancer Study
Substantially all planned REO 033 clinical sites are now activated, with multiple patients currently on study Company expects to have sufficient Part A data to provide an interim clinical update by year-end 2026 FDA alig
Kazia Therapeutics Reports Preclinical Data Showing Paxalisib Reprograms Immunotherapy-Resistant MSS/pMMR Colorectal Cancer and Enhances Response to Immunotherapy
Paxalisib Monotherapy Significantly Reduced Tumor Burden in Pre-Clinical Model of MSS/pMMR Colorectal Cancer, With the Addition of Pembrolizumab Driving a Further Reduction Paxalisib Was Well Tolerated as Monotherapy and
Agenus Announces Peer-Reviewed Publication Linking BOT+BAL's Durable Survival in MSS Metastatic Colorectal Cancer to Its Distinct Immune-Priming Mechanism
[url="]Agenus[/url] Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the peer-reviewed publication of mature Phase 1b results from t
Maison Solutions Eliminates All Outstanding Convertible Notes, Removing Legacy Financing Overhang
Completion Removes the Remaining Conversion Overhang Associated With the Company's Convertible Note Financing and, Management Believes, Enhances Financial and Strategic Flexibility MONTEREY PARK, CA / ACCESS Newswire / A
Maison Solutions Inc. Receives Nasdaq Notification Regarding Delayed Filing of Annual Report on Form 10-K
MONTEREY PARK, CA / ACCESS Newswire / August 25, 2026 / Maison Solutions Inc. (Nasdaq:MSS) (the "Company") today announced that, on August 20, 2026, it received a notification letter from the Listing Qualifications staff